ESMO: Targeted Anticancer Therapies Congress 2024
Novel cancer targets and agents presented at the ESMO Targeted Anticancer Therapies Congress 2024, which took place Feb. 26-28, in Paris, France.
Cancer organoid-based drug sensitivity tests have recently been investigated to predict responses to anticancer drugs.
Role of MicroRNAs on Anti-Apoptotic MCL-1/cIAP-2 Gene Expression in Patients With EGFR-Mutated NSCLC
A study that assessed the impact of miR-29a and miR-143 on gene expression in lung cancer.
A study examined whether AI and clinical knowledge can identify more patients with lung and ovarian cancers.
A study detailed the landscape of lung adenocarcinoma progression.
MK-1084 as monotherapy and in combination with pembrolizumab is effective in patients with NSCLC.
Advertisement
Advertisement
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.